# Cannabis

Type: Product

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/cannabis
Canonical HTML page: https://gethealthbrief.com/entity/cannabis

## Recent coverage (1 stories)

### Cannabis Compounds Show Potential to Reverse MASLD in One-Third of Adults
2026-03-10 03:33:08 · Sentiment: Positive · Impact: 6/10 · Sources: 2

Emerging clinical research indicates that specific cannabis-derived compounds may reverse Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a condition affecting nearly 33% of the global adult population. This discovery could shift the treatment paradigm for a disease that currently has few FDA-approved pharmacological interventions.
Full story: https://gethealthbrief.com/story/cannabis-compounds-masld-liver-disease-breakthrough

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.